Obtain mechanistic understanding and novel insights into disease biology.

Speed up

Speed up your early R&D process and reduce your time to decision making.


Identify targets and lead compounds with potential to produce first-in-class medicines.
Our services

An approach you can trust

We are seasoned specialists in providing neurobiology research services. Our mission is to create groundbreaking in vitro concepts that will advance the neuroscience research field and enable our Clients to conduct successful drug discovery programs.
Read more arrow_forward

Basic research

From deciphering disease mechanisms to exploration of novel assay concepts.

Target discovery

Using functional genomics and advanced in vitro models we help our Clients to identify and validate novel targets.

Lead discovery

Phenotypic and target-based assay development, screening and lead optimization.
Our platform

Elevated neurobiology in vitro research

What sets us apart from the competition is our unique discovery platform. By combining drug discovery expertise and disease area knowledge with cutting-edge technologies, we create complex disease models and assays for functional and morphological screening.
Read more arrow_forward

News and events

Latest news and insights

Cellectricon values scientific exchange and we invite you to take part of our latest news and to learn about upcoming events.

Read more

Cellectricon is looking for a scientist to join our team
Cellectricon is an innovative services provider dedicated to advancing drug discovery and research in the areas of peripheral neuropathies, neuroplasticity...
Cellectricon receives CIR (French Research Tax Credit) accreditation
MÖLNDAL, SWEDEN Cellectricon AB, a services provider dedicated to advancing neuroscience drug discovery, today announced that it has received CIR...
Cellectricon expands neuroscience contract research portfolio with new Neuroplasticity services
Mölndal, Sweden Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, today announced the launch of a new service...
November 11-15, 2023
Neuroscience 2023
The Neuroscience 2023 meeeting takes place in Washington D.C. on November 11-15. During the conference, we will present several posters...
October 10-12, 2023
Neuropsychiatric Drug Development Summit
The 6th Neuropsychiatric Drug Development Summit takes place in Boston, US on October 10-12. The meeting focuses on the advancement...
Delix Therapeutics partners with Cellectricon, Expressive Neuroscience and expands science team to accelerate drug discovery and translatability
We’re excited to be working with Delix Therapeutics and support their development of neuroplasticity-promoting therapeutics! At Cellectricon, we solve our...
June 6-7, 2023
Discovery Europe 2023
Discovery Europe and the Neuroscience Drug Development Europe meetings take place in parallel in Berlin, Germany on June 6-7, 2023....
March 28 - April 1, 2023
AD/PD 2023
The AD/PD 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders takes place in Gothenburg, Sweden on...
Cellectricon strengthens IP portfolio – Receives “Intention to Grant” from the European Patent Office
Cellectricon AB, a leading provider of neurobiology in vitro research services, today announced that the company received notice of intention...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Social media

Cellectricon on LinkedIn

Follow us on LinkedIn

Webcasts and videos

Check out our YouTube channel to view select webcasts and presentations from our in-house experts and collaborators.

Follow us on YouTube